Prothena Corp saw the highest growth of 0.66% in patent filings in April and 2.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.66% and grants by 0.32%. GlobalData’s DataBook provides a comprehensive analysis of Prothena Corp’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Prothena Corp has been focused on protecting inventions in United States(US) with five publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 25% grants. The United States(US), Australia(AU), and Japan(JP) patent Office are among the top ten patent offices where Prothena Corp is filings its patents. Among the top granted patent authorities, Prothena Corp has 50% of its grants in Australia(AU), 25% in United States(US) and 25% in Japan(JP).
Regeneron Pharmaceuticals and Immatics could be the strongest competitors for Prothena Corp
In terms of grant share, Prothena Corp stands in seventh position among its competitors. Regeneron Pharmaceuticals and Immatics secured the top positions according to recent patent publication data.
Patents related to healthtech and rare diseases lead Prothena Corp's portfolio
Prothena Corp has the highest number of patents in healthtech followed by, rare diseases. For healthtech, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Alzheimer's disease related patents lead Prothena Corp portfolio followed by parkinson's disease, and frontotemporal dementia with parkinsonism-17 (ftdp-17)
Prothena Corp has highest number of patents in alzheimer's disease followed by parkinson's disease, frontotemporal dementia with parkinsonism-17 (ftdp-17), amyotrophic lateral sclerosis, and batten disease. For alzheimer's disease, nearly 10% of patents were filed and 22% of patents were granted in Q2 2024.
For comprehensive analysis of Prothena Corp's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
